Provide treatment to over 9 million people worldwide that are infected with tuberculosis. Tuberculosis treatment standards require healthcare workers to directly observe patients taking medication
TB patients, clinicians.
miDOT is a smartphone application that allows patients to indicate symptoms and record themselves taking their medication. The patient can then securely submit this information to the emocha server, where a clinician can then observe and confirm medication adherence using the emocha web interface. The system also includes a notifications feature to remind patients to take their medication and inform providers about important patient-reported events.
Emocha provides Help Desk support.
miDOT has already been implemented in Harris County (TX) and Baltimore (MD). Data is actively being gathered on usability, patient adherence, and cost savings at four Maryland health departments with support from an NIH grant. miDOT is also being used in an adherence-related study of Hepatitis C Virus in Denver, CO. miDOT will soon be tested in Pune and Bangalore, India.
If you are experiencing the following symptoms, notify a nurse or local health care provider immediately before continuing medication:
- Skin Rash
- Loss of Appetite
- Abdominal Pain/Diarrhea
- Sores in Mouth
- Jaundice (Yellow Skin/Eyes)
- Joint Pain/Swelling
Prescribed TB drugs, mobile phone camera
Hoffman, J. A., Cunningham, J.R., Suleh, A.J., Sundsmo, A., Dekker, D., Vago, F., Munly, K., Igonya, E. K., Hunt-Glassman, J. Mobile direct observation treatment for tuberculosis patients: a technical feasibility pilot using mobile phones in Nairobi, Kenya. Am J Prev Med. 2010 Jul; 39(1):78-80.
Emocha was awarded the Small Business Innovation Research (SBIR) award by NIH.
In context photographs (0)
You can use the form below to contribute a photo of this product.
In context files & documents (0)
Feedback from users, customers & distributors
Please let us know your experience in using this product through comments below.